Bile Duct Cancer Clinical Trials

93 clinical trials for Bile Duct Cancer across international registries, including 18 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer — RECRUITING
• Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types — RECRUITING · PHASE1
• PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma — RECRUITING · PHASE2
• Integrated Cancer Repository for Cancer Research — RECRUITING
• Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer — RECRUITING · PHASE2
• Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma — RECRUITING · PHASE2
• Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio — RECRUITING · PHASE2
• A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC) — RECRUITING · PHASE1
• Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes — RECRUITING · NA
• Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas — RECRUITING · PHASE3
• Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma — RECRUITING · NA
• Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE) — RECRUITING
• Spanish Registry of Digestive Tumours RETUD — RECRUITING
• EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope — RECRUITING · NA
• Modified vs Conventional Blumgart Anastomosis of LPD for the Effects of Pancreatic Fistula of Periampullary Carcinoma — RECRUITING · NA
• A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors — RECRUITING · PHASE1
• A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN) — RECRUITING
• Prognostic Factors in Periampullary Tumors and Cysts — RECRUITING
• TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE) — NOT_YET_RECRUITING · NA
• Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC) — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors — TERMINATED · PHASE2
• Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors — TERMINATED · PHASE1
• The Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary Zone — COMPLETED · NA
• Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors — COMPLETED · PHASE1
• Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder — COMPLETED · PHASE1
• Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents — ACTIVE_NOT_RECRUITING · NA
• A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. — TERMINATED · PHASE1
• Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors — TERMINATED · PHASE2
• A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 — COMPLETED · PHASE1
• Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab — COMPLETED · PHASE1
• The Registry of Oncology Outcomes Associated With Testing and Treatment — COMPLETED
• CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors — OTHER · PHASE1
• Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms — COMPLETED · NA
• Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE2
• Outcomes and Prognostic Factors in Hepatopancreatoduodenectomy — COMPLETED
• Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors — OTHER · PHASE1
• DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract Cancer — OTHER · PHASE2
• AZD6738 Plus Durvalumab in Biliary Tract Cancer — OTHER · PHASE2
• Quebec Pancreas Cancer Study — OTHER
• Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma — OTHER · NA
• Recurrence After Whipple's (RAW) Study — COMPLETED
• Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC). — TERMINATED · PHASE2
• Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene — COMPLETED · PHASE1
• Combined Treatment of Treated Bile Duct Cancer — OTHER · PHASE2
• Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy — COMPLETED · PHASE3
• A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC) — COMPLETED · PHASE2

Refine this search